Vemurafenib and cobimetinib in BRAF-mutated melanoma

Lancet Oncol. 2014 Nov;15(12):e535. doi: 10.1016/s1470-2045(14)71023-x. Epub 2014 Oct 10.
No abstract available

Publication types

  • News

MeSH terms

  • Azetidines / therapeutic use*
  • Humans
  • Indoles / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Mutation
  • Piperidines / therapeutic use*
  • Proto-Oncogene Proteins B-raf / genetics
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Azetidines
  • Indoles
  • Piperidines
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • cobimetinib